TCM prescriptions have been reported to effectively intervene in PLGC (including chronic atrophic gastritis [CAG], GIM, and dysplasia) via the PI3K/Akt/mTOR or EGFR/PI3K/Akt pathways [4, 27]. The gene discussed is AKT1; the disease is chronic atrophic gastritis.